Quarterly Earnings: Experion, InMed Pharmaceuticals, Smoke Cartel

Here’s a summary of the latest earnings and operational updates in the cannabis industry.

InMed Pharmaceuticals Posts Record Net Loss Of $11.9M

InMed Pharmaceuticals Inc. (TSX: IN) (OTCQX: IMLFFreported its earnings for the fiscal year 2020.

The Vancouver-based company posted a record net loss of $11.9 million, versus a net loss of $13.3 million for the last year.

In addition, its research and development expenses were $7.1 million, up by around 27% compared to the previous year.

Its general and administrative expenses decreased by approximately 8% over the year to $3.5 million.

The company’s cash equivalents and short-term investments amounted to $8 …

Full story available on Benzinga.com

More Quarterly Earnings: Experion, InMed Pharmaceuticals, Smoke Cartel